A new primary research firm

The depth of a consulting firm.The speed of a platform.

Same researchers you'd hire from McKinsey, LEK, or Bain — running mixed-method studies on an AI-native stack. Full deliverables in 7-10 days.

Final Report
HCLS · Diagnostics Strategy
NGS Oncology IVD Market Assessment
Confidential · Prepared Q1 2026
0
Interviews
5
Countries
10
Days
Adoption Intent by Lab Type
Academic
78%
Reference
64%
Community
41%
Strategic Impact
Findings reshaped the client's 3-year strategic plans for their diagnostics portfolio.
Final Report
PE · Commercial Due Diligence
Warehouse Automation Market Intelligence
Confidential · Prepared Q4 2025
0
Interviews
3
Segments
10
Days
Automation Investment Plans (2025-2028)
Expand
80%
Maintain
15%
Reduce
5%
Demand Thesis Validated
80% plan automation projects 2025-2028. Identified switching triggers and quantified aftermarket services moat.
Final Report
Pharma · Pricing Strategy
Specialty Biologic Willingness-to-Pay
Confidential · Prepared Q1 2026
0
Interviews
Mixed
Method
10
Days
Physician vs Payer Price Acceptance
Physicians
72%
Payers
38%
Gap
34%
Access Gap Identified
Critical misalignment between physician pricing preferences and payer coverage — caught before launch.
Final Report
PE · Pre-LOI Diligence
Diagnostic Test Market Adoption Forecasting
Confidential · Prepared Q4 2025
0
Interviews
4
Countries
8
Days
Adoption Intent vs Sponsor Base Case
Actual Intent
82%
Base Case
52%
Upside
30%
+30% vs Base Case
Adoption intent among community pathologists was 30% higher than the sponsor's base case. Changed the deal thesis.
Final Report
MedTech · Customer Insight
Cardiac Monitoring Device Adoption Study
Confidential · Prepared Q1 2026
0
Interviews
3
Specialties
10
Days
Adoption Intent by Specialty
EM
88%
Cardiology
65%
Primary Care
42%
Unexpected Champion
EM physicians emerged as the surprise champion segment — reshaped the entire commercial launch strategy.

Trusted by research leaders at

I'm definitely concerned that this may make consulting obsolete in many cases... Wait weeks for a report, or get the same depth of insight in days... let me think!!
Stephane Budel— CEO, DeciBio

Depth and scale.
For every study.

Surveys give you numbers without meaning. Expert calls give you meaning without scale. UserCue runs real human panels through a full mixed-method study design, recruit, quant, qual, analysis, an enterprise-grade report, and clear insights all in one engagement.

Advanced Quant Methodologies
Choice-based conjoint, MaxDiff scaling, Van Westendorp price sensitivity full statistical rigor, native to the platform.
AI-Moderated Interviews
The AI probes deeper surfacing trade-offs and the “why” behind decisions. Hundreds of interviews simultaneously, no scheduling, no transcription delay.
Real-Time Synthesis
Thematic, sentiment, and entity analysis in real-time every response coded and tagged the moment the interview ends.
Enterprise-Grade Deliverable
Executive summary, segmentation, verbatim quotes, methodology, charts ready in days, not months.
Physicians
Executives
Payers
Scientists

Sourcing verified domain experts from every major research network worldwide.

Recruiting in progress...
Sample size range per studyN = 50 – 2,000+
Question 12 of 2435%

How important are these attributes when prescribing for high-risk BRAF-mutated patients?

Endoscopic improvement
Clinical symptoms
Cardiovascular safety
Durability of response
AI-Moderated Depth Interview●●●○
Research.OSWhat’s most important when prescribing for high-risk BRAF-mutated patients?
Recording…
RespondentDurability and safety over time. Sustained response past 12 months changes the algorithm.
Research.OS · follow-upAt 12, 18, or 24 months — which threshold flips your first-line choice?
Trade-off · Best vs Worst7 / 12

Of these four, which is most important and which is least?

Endoscopic improvement
Sustained durability > 12mo
Symptom relief at week 4
Hospitalization rate (annual)
UserCue · Final Report
Lab Instruments & Consumables Landscape
Confidential · Prepared Q1 2026
157Interviews
5Countries
10Days
42 pages · Mixed Method
Findings · Purchase Priorities Heatmap
Performance897491
Support648355
Reliability954887
Innovation689361
Indexed · blinded values
Top Themes · N=157 Depth Interviews
Vendor consolidation fatigue
Price-performance shifts
Workflow automation
Supply chain reliability
Vendor Share of Wallet
Market Leader 34%
Challenger 24%
Specialty 18%
Legacy 14%
Delivered in 7–10 Days
Mixed-method quant survey · Likert ratings
The Old Way vs. UserCue

Same insights.
Different math.

What used to cost $500K and take 12 weeks now costs $30K and takes 10 days. Same researchers from McKinsey, LEK, and Bain — different stack, different math.

vs
The Traditional Way

McKinsey, Bain, LEK…

Tier-1 consulting firms & legacy research agencies

$150K – $750K per study
Six-figure proposals, custom SOWs, multi-phase invoicing
6 – 12+ weeks per project
RFP cycles, recruiting, transcription, deck assembly
Qual or Quant — pick one
Two separate workstreams, two budgets, two timelines
Re-cuts in days or weeks
Follow-up questions require new SOWs and analyst time. Deliverable formats are fixed once shipped.
The Research.OS Way

UserCue.

Built by ex-McKinsey, LEK, c_space & Bain researchers

$30K per pilot
Fixed-fee, predictable, no scope creep — 1/10th the cost
7 – 10 days, intake to delivery
In field within 24 hours. No RFP. No vendor selection.
Mixed-method native
Quant rigor + qual depth in a single AI-moderated session
Editorial-grade reports, in any format
On-demand re-cuts and follow-ups in hours, not weeks. Long-form PDFs, dashboards, branded decks — whatever your team needs.
10x faster
Days, not months
Skip the 6–12 week RFP cycle. Most studies live in field within 24 hours of intake.
Quant + Qual
Both, every time
AI-moderated interviews capture statistical rigor AND deep narrative — in a single session.
Top 1%
Same researchers, better tools
Ex-McKinsey, LEK, c_space, Bain. The talent that runs your study used to charge 5x more.
Unlimited
Run research like a muscle
PE firms run a study every week, not 5 per year. Strategic insight on demand, not a one-shot ask.

Experts steer. Agents execute.
End-to-end.

Recruiting and mixed-method surveys are just two stops on the line. Behind every study is a full team of researchers — from LEK, DeciBio, GLG — steering a fleet of specialized AI agents from kickoff to final deliverable.

How it works ↓

Project lead
Your team + oursScopes the study together.
Dedicated lead from day one
Research designer
Research designerRefines guide, screener, sample.
Ex-LEK · DeciBio · GLG
QC specialist
QC specialistMonitors every interview live.
Trained QC agents + human review
Domain analyst
Domain analystValidates themes and rigor.
Ex-LEK · Leerink · c_space
Senior researcher
Senior researcherAuthors the final report.
Trusted by Top-10 pharma
00
Client Kickoff
Define objectives and parameters together.
Expert role:Translate business questions into research design.
Agent 01
Study Designer
Drafts guide, screener, and sample from past precedents.
Expert role:Reviews and approves the draft.
Agent 02
Mixed-Method Moderator
Runs sessions with real-time probing and QC.
Expert role:Flags and removes bad data live with QC agents.
Agent 03
Analyzer
Quant + qual analysis across specialized skills.
Expert role:Built on real analyst workflows.
Agent 04
Reporter
Synthesizes findings into the final report.
Expert role:Packages into enterprise-grade deliverables.
Average Project Time: 7-10 Days
One operating system. Brief to full study.
  1. Stage 00 · Kickoff

    Client kickoff

    Intake + briefing. Define objectives, audience, parameters.

    Your team + ours scopes the study together — dedicated project lead from day one.
  2. Agent 01 · Design

    Study designer

    Drafts discussion guide, screener & sampling plan from past precedents.

    Research designer reviews and refines — ex-LEK · DeciBio · GLG.
  3. Agent 02 · Field

    Mixed-method moderator

    Moderates quali-quant sessions with probing and real-time QC.

    QC specialist monitors every interview — trained QC agents plus human review.
  4. Agent 03 · Analysis

    Analyzer

    Complex quant and qual analyses across specialized skills.

    Domain analyst validates themes and statistical rigor — ex-LEK · Leerink · c_space.
  5. Agent 04 · Report

    Reporter

    Synthesize insights into reports tied to objectives.

    Senior researcher curates insights and authors the final deliverable — trusted by Top-10 pharma.

Every methodology, every vertical.

From pre-LOI diligence to KOL mapping, from conjoint to claims testing — if you’ve ever paid a consulting firm to do it, we deliver it in days.

Private Equity & Financial Sponsors
Market landscapingTAM validationPre-LOI diligenceCompetitive positioningRapid VOCCustomer journey mappingBuyer persona validationDemand driver assessmentChannel partner ecosystemIndustry growth forecastingAdjacent market opportunityCompetitor cost structureMarket landscapingTAM validationPre-LOI diligenceCompetitive positioningRapid VOCCustomer journey mappingBuyer persona validationDemand driver assessmentChannel partner ecosystemIndustry growth forecastingAdjacent market opportunityCompetitor cost structure
Deep VOC & churn-riskPricing power & WTPSupply-chain resilienceService-line expansionIntegration feasibilityProduct roadmap validationSwitching cost assessmentNeeds-based segmentationCross-sell/upsell trackingNPS driver analysisBrand equity progressionInnovation pipelineDeep VOC & churn-riskPricing power & WTPSupply-chain resilienceService-line expansionIntegration feasibilityProduct roadmap validationSwitching cost assessmentNeeds-based segmentationCross-sell/upsell trackingNPS driver analysisBrand equity progressionInnovation pipeline
Healthcare & Life Sciences
KOL mappingPatient flow / line of therapyConcept screeningClaims & creative testingTPP optimizationVan Westendorp pricingConjoint analysisMaxDiff / TURFPayer accessAI-moderated IDIsAdvisory boardsMixed-method designsKOL mappingPatient flow / line of therapyConcept screeningClaims & creative testingTPP optimizationVan Westendorp pricingConjoint analysisMaxDiff / TURFPayer accessAI-moderated IDIsAdvisory boardsMixed-method designs
PharmaBiotechMedTechDiagnosticsDigital healthHealth ITPayersCROs & CDMOsLife-science toolsPublic health / HTAPharmaBiotechMedTechDiagnosticsDigital healthHealth ITPayersCROs & CDMOsLife-science toolsPublic health / HTA

And much more — we run any custom methodology your engagement requires.

What leaders are saying.

“I'm from a management consulting background and I fear for new strategy management consultants after our experience with UserCue.”
Partner
Venture Capital, $2B+ AUM
“Speed was amazing! They told us over and over again how thrilled they were with what we gave them. The ability to get it fielded in time was really impressive.”
Director
Global Market Research Firm
That was the fastest study I've ever done.
Engagement Lead
Global Management Consultancy
“It was quite impressive how quickly you recruited and managed to get to 200+ interviews. It took me a couple of redbulls to read it all.”
Managing Director
Healthcare Private Equity
“You have done what you said you would — combined access, tech and consultant experience to deliver a lot of well-organised material.”
CEO
Life Sciences Company
This report may be my favorite document of the year.
Research Director
Healthcare Services Company
“I'm from a management consulting background and I fear for new strategy management consultants after our experience with UserCue.”
Partner
Venture Capital, $2B+ AUM
“Speed was amazing! They told us over and over again how thrilled they were with what we gave them. The ability to get it fielded in time was really impressive.”
Director
Global Market Research Firm
That was the fastest study I've ever done.
Engagement Lead
Global Management Consultancy
“It was quite impressive how quickly you recruited and managed to get to 200+ interviews. It took me a couple of redbulls to read it all.”
Managing Director
Healthcare Private Equity
“You have done what you said you would — combined access, tech and consultant experience to deliver a lot of well-organised material.”
CEO
Life Sciences Company
This report may be my favorite document of the year.
Research Director
Healthcare Services Company
“UserCue makes these projects so straightforward that it's almost hard to remember the old days when projects would take three months or more. Almost.”
Client Lead
Life Sciences Reagents Company
The competition is nowhere close to where you're at right now.”
Managing Director
PE Fund
“You guys are now the most wanted tool for the whole company. I'm trying to hop in the queue before somebody jumps in front of me.”
VP, Operations
Healthcare Technology Company
“I was impressed most by the speed. With the depth of the report, I would have expected it to take another month.
Stakeholder
Life Sciences Reagents Company
“Love the product you have built. Hopefully this will give us an edge in our work.”
Partner
Tech & Software Private Equity
“We are extremely impressed with the quality you pulled together in such a condensed timeframe. Look forward to running it back.”
Client Team
Healthcare Private Equity
“UserCue makes these projects so straightforward that it's almost hard to remember the old days when projects would take three months or more. Almost.”
Client Lead
Life Sciences Reagents Company
The competition is nowhere close to where you're at right now.”
Managing Director
PE Fund
“You guys are now the most wanted tool for the whole company. I'm trying to hop in the queue before somebody jumps in front of me.”
VP, Operations
Healthcare Technology Company
“I was impressed most by the speed. With the depth of the report, I would have expected it to take another month.
Stakeholder
Life Sciences Reagents Company
“Love the product you have built. Hopefully this will give us an edge in our work.”
Partner
Tech & Software Private Equity
“We are extremely impressed with the quality you pulled together in such a condensed timeframe. Look forward to running it back.”
Client Team
Healthcare Private Equity

Give us your toughest
research question.

$30K pilot. Full deliverable in 7-10 days. No long-term commitment. See it for yourself.